Niu Heyuan, Du Haipeng, Ji Zhe, Li Xiaoping, Xiao Wanyi, He Anqi, Yu Ping, Liu Gang
Department of General Surgery, Tianjin Medical University General Hospital, 154 Anshan Road, Tianjin, 300052, People's Republic of China.
Department of Gastrointestinal Surgery, Tianjin Medical University Baodi Hospital, Tianjin, China.
Discov Oncol. 2025 Jun 1;16(1):978. doi: 10.1007/s12672-025-02716-8.
Cancer poses a significant health threat, causing millions of deaths annually. Although chemotherapy-based comprehensive therapies are common, their low accuracy and severe side effects limit effectiveness. Metal-organic frameworks (MOFs), with their superior biocompatibility and stability, show great promise for drug delivery and cancer treatment. This study aims to explore the potential and developmental trajectories of MOFs in cancer research through a bibliometric analysis.
The Web of Science Core Collection was searched for documents from its inception in 2009 to December 31, 2023. We analyzed and visualized document types, countries, institutions, authors, journals, references, and keywords using the Bibliometrix package, dplyr, sankeywheel, term extraction, and ggplot2. Additionally, the Latent Dirichlet Allocation (LDA) algorithm was employed for detailed semantic analysis, uncovering latent thematic distributions.
A total of 7106 authors from 1591 institutions across 45 countries contributed 1955 papers on MOFs in cancer research, published in 327 journals. China leads in research output and international collaboration, with the Chinese Academy of Sciences as the top institution. Lin Wenbin from the University of Chicago is the most influential author, and ACS Applied Materials & Interfaces is the most active journal. MOFs are predominantly studied for breast cancer, followed by lung and liver cancers. Drug delivery remains a focal point for future research.
This study provides a comprehensive overview of the research landscape on MOFs in cancer treatment, offering insights into key trends and future directions, particularly in drug delivery and disease-specific applications.
癌症对健康构成重大威胁,每年导致数百万人死亡。尽管基于化疗的综合疗法很常见,但其低准确性和严重副作用限制了疗效。金属有机框架(MOF)具有卓越的生物相容性和稳定性,在药物递送和癌症治疗方面显示出巨大潜力。本研究旨在通过文献计量分析探索MOF在癌症研究中的潜力和发展轨迹。
在科学网核心合集中检索2009年创刊至2023年12月31日的文献。我们使用Bibliometrix包、dplyr、sankeywheel、术语提取和ggplot2对文献类型、国家、机构、作者、期刊、参考文献和关键词进行了分析和可视化。此外,采用潜在狄利克雷分配(LDA)算法进行详细的语义分析,揭示潜在的主题分布。
来自45个国家1591个机构的7106位作者发表了1955篇关于MOF在癌症研究中的论文,发表在327种期刊上。中国在研究产出和国际合作方面领先,中国科学院是排名第一的机构。芝加哥大学的林文斌是最具影响力的作者,《美国化学会应用材料与界面》是最活跃的期刊。MOF主要用于乳腺癌研究,其次是肺癌和肝癌研究。药物递送仍然是未来研究的重点。
本研究全面概述了MOF在癌症治疗方面的研究概况,深入了解了关键趋势和未来方向,特别是在药物递送和疾病特异性应用方面。